- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02588209
Cognitive Screening and Cognitive Training in Seniors
October 25, 2023 updated by: The University of Texas at Dallas
This study will provide cognitive screenings for seniors age 50 and older.
It will also investigate the benefits of two different cognitive training programs for seniors who have lower baseline performance on memory and/or gist reasoning tests.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study consists of two parts which includes cognitive screening and cognitive training.
Participants will initially participate in the cognitive screening portion of the study.
If qualified, participants will participate in the cognitive training portion of this study which includes additional cognitive communication, neuropsychological testing, and EEG.
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75235
- UTD Center for BrainHealth
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Cognitive complaints in the absence of dementia
- Participate in tasks involving motor abilities such as use of at least one arm and hand
- Read, speak, and comprehend English
- At least 50 years of age
- Comprehend simple instructions, perform tasks, and take part in intervention
Exclusion Criteria:
- Not proficient in reading,comprehending, and speaking English
- History of learning disability, stroke, cognitive impairment, major psychiatric illness, alcoholism, or substance abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SMART Training
This group will receive the Strategic Memory Advanced Reasoning Training (SMART) program, twice a week for four weeks.
|
SMART teaches strategies to improve the ability to process information.
Other Names:
|
Active Comparator: Health
This group will receive the Brain Health Workshop educational program, twice a week for four weeks.
|
Brain Health Workshop provides information about brain health in a seminar format.
Topics include: sleep, nutrition, and exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement in memory or thinking after brain training
Time Frame: beginning (0 weeks) to end (4 weeks)
|
To examine short-term effects of treatment on cognition using neuropsychological measures
|
beginning (0 weeks) to end (4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measures changes in brain wave activity
Time Frame: beginning (0 weeks) and end (4 weeks)
|
Electrophysiological responses will be recorded using event related potential to monitor responses to yes/no stimuli.
|
beginning (0 weeks) and end (4 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sandra Chapman, PhD, Center for Brain Health, University of Texas at Dallas
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
October 23, 2015
First Submitted That Met QC Criteria
October 26, 2015
First Posted (Estimated)
October 27, 2015
Study Record Updates
Last Update Posted (Actual)
October 30, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RGK11-52
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Centre for Addiction and Mental HealthRecruitingAmnestic Mild Cognitive ImpairmentCanada
-
University of FloridaNational Institute on Aging (NIA)RecruitingAmnestic Mild Cognitive ImpairmentUnited States
-
Charite University, Berlin, GermanyCompletedMild Cognitive Impairment (MCI)Germany
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedMild Cognitive Impairment (MCI)United States
Clinical Trials on Strategic Memory Advanced Reasoning Training
-
The Defense and Veterans Brain Injury CenterThe University of Texas at DallasRecruitingMild Traumatic Brain InjuryUnited States
-
Dr. Kristin SamuelsonCompletedTraumatic Brain Injury | Posttraumatic Stress Disorder
-
The University of Texas at DallasNational Institutes of Health (NIH)CompletedHearing ImpairedUnited States
-
The University of Texas at DallasUniversity of TexasCompletedBipolar Disorder | Cognitive Ability, General
-
University of FloridaCompletedReasoning TrainingUnited States
-
Hochschule OsnabruckMedizinische Gesellschaft für Myofasziale Schmerzen e.V.; Therapiecentrum Voxtrup... and other collaboratorsRecruitingNeck Pain | Temporomandibular DisorderGermany
-
Johns Hopkins UniversityTerminatedSubstance-Related DisordersUnited States
-
National Medical Research Council (NMRC), SingaporeAlexandra Hospital; St Luke's Hospital, Singapore; National University of SingaporeCompleted
-
Icahn School of Medicine at Mount SinaiCompletedDepression | Generalized Anxiety Disorder | Bipolar Disorder | Major Depressive Disorder | Social Phobia | Post-traumatic Stress DisorderUnited States
-
University of GeorgiaRecruitingSchizophrenia | Schizo Affective DisorderUnited States